0001638599-18-001117.txt : 20180920
0001638599-18-001117.hdr.sgml : 20180920
20180920161749
ACCESSION NUMBER: 0001638599-18-001117
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180918
FILED AS OF DATE: 20180920
DATE AS OF CHANGE: 20180920
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MATHER CHARLES E IV
CENTRAL INDEX KEY: 0001563422
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38365
FILM NUMBER: 181079649
MAIL ADDRESS:
STREET 1: C/O TONIX PHARMACEUTICALS HOLDING CORP
STREET 2: 509 MADISON AVE., SUITE 306
CITY: NEW YORK
STATE: NY
ZIP: 10022
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: EYENOVIA, INC.
CENTRAL INDEX KEY: 0001682639
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 471178401
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 8748 TECHNOLOGY WAY
CITY: RENO
STATE: NV
ZIP: 89521
BUSINESS PHONE: 813-766-9539
MAIL ADDRESS:
STREET 1: 8748 TECHNOLOGY WAY
CITY: RENO
STATE: NV
ZIP: 89521
4
1
doc4_5697.xml
PRIMARY DOCUMENT
X0306
4
2018-09-18
0
0001682639
EYENOVIA, INC.
EYEN
0001563422
MATHER CHARLES E IV
C/O EYENOVIA, INC.
501 FIFTH AVENUE, SUITE 1404
NEW YORK
NY
10017
1
0
0
0
Common Stock, par value $.0001
2018-09-18
4
P
0
1000
4.80
A
5033
D
Common Stock, par value $.0001
2018-09-19
4
P
0
3000
4.78
A
8033
D
Stock Option (right to buy)
6.20
2028-07-24
Common Stock
4465
4465
D
This transaction was executed in multiple trades ranging from $4.75 to $4.7885. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder full information regarding the number of shares and prices at which the transactions were effected.
The option becomes exercisable on the earlier of July 24, 2019 or the date of the Issuer's 2019 annual meeting of stockholders, subject to the Reporting Person's continued service on the Issuer's Board of Directors and acceleration upon change in control.
/s/ S. Halle Vakani, Attorney-in-Fact
2018-09-20